huPD-L1/LAG3

Model Information:

This HuGEMM model consist of chimeric PD-L1 and LAG3, which is an appropriate platform for testing the combination of human anti-PD-L1 and human anti-LAG3 antibody evaluation.

Summary
Cancer Type	N/A
Type	Double Knock-In
Target	Human PD-L1/LAG3
Mouse Strain	C57BL/6

Validation of Human Target Expression

Additional Characteristics

Response to Immunotherapy